Futura Medical plc develops and commercializes consumer health products focused on sexual health. The company’s lead product, Eroxon®, is a clinically proven topical gel for the treatment of erectile dysfunction, available over the counter in multiple markets including Europe and the USA. Futura is also developing WSD4000, a portfolio of topical gels aimed at addressing female sexual dysfunction. The company operates a hybrid business model that combines research and development with commercial partnerships to enhance market reach and sustainability. Futura is based in Guildford, United Kingdom, and targets global consumer healthcare markets.